Author Topic: NY Times: Cutting Dosage of Costly Drug Spurs a Debate  (Read 1199 times)

0 Members and 1 Guest are viewing this topic.

Offline feedbot

  • Επίλεκτο μέλος
  • *****
  • Posts: 6686
  • Κάπνισμα: Δεν κάπνισα ποτέ
Cutting Dosage of Costly Drug Spurs a Debate
     


A drug for a rare enzyme deficiency can cost $300,000 a year, making the right dose a matter of public debate.
     

http://www.nytimes.com/2008/03/16/business/16gaucher.html?ex=1363406400&en=31b133c9d6628e6f&ei=5088&partner=rssnyt&emc=rss